Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4226
Titan Machinery
TITN
$458M
| $790K | ﹤0.01% |
68,394
+7,578
| +12% | +$74.5K |
|
|
ENZ
4227
DELISTED
Enzo Biochem, Inc.
ENZ
| $790K | ﹤0.01% |
173,561
+67,322
| +63% | +$300K |
|
|
CY
4228
CALL
DELISTED
Cypress Semiconductor
CY
| $790K | ﹤0.01% |
91,200
-303,800
| -77% | -$2.45M |
|
4229
CALL
Murphy Oil
MUR
$5.17B
| $788K | ﹤0.01% |
31,300
+3,500
| +13% | +$70.1K |
|
|
XONE
4230
CALL
DELISTED
The ExOne Company
XONE
| $788K | ﹤0.01% |
60,000
+38,800
| +183% | +$370K |
|
4231
PUT
Canadian National Railway
CNI
$77.1B
| $787K | ﹤0.01% |
12,600
+2,500
| +25% | +$140K |
|
4232
iShares MSCI USA Equal Weighted ETF
EUSA
$1.87B
| $787K | ﹤0.01% |
18,454
+169
| +0.9% | +$6.78K |
|
|
SCHW
4233
PUT
Charles Schwab
SCHW
$188B
| $787K | ﹤0.01% |
28,100
-132,900
| -83% | -$3.51M |
|
|
RSPP
4234
CALL
DELISTED
RSP Permian, Inc.
RSPP
| $787K | ﹤0.01% |
+27,100
| New | +$637K |
|
|
BLUE
4235
CALL
DELISTED
bluebird bio
BLUE
| $786K | ﹤0.01% |
1,428
-888
| -38% | -$545K |
|
4236
CALL
Generac Holdings
GNRC
$12.8B
| $786K | ﹤0.01% |
21,100
-376,500
| -95% | -$12.1M |
|
4237
ProShares UltraShort Real Estate
SRS
$15.2M
| $786K | ﹤0.01% |
2,497
-28
| -1% | -$10.6K |
|
|
TA
4238
DELISTED
TravelCenters of America LLC
TA
| $786K | ﹤0.01% |
23,209
-331
| -1% | -$12.8K |
|
|
VIVO
4239
DELISTED
Meridian Bioscience Inc
VIVO
| $782K | ﹤0.01% |
37,954
-91,048
| -71% | -$1.79M |
|
4240
PUT
Microchip Technology
MCHP
$42.2B
| $781K | ﹤0.01% |
32,400
+19,400
| +149% | +$432K |
|
4241
Ollie's Bargain Outlet
OLLI
$4.74B
| $781K | ﹤0.01% |
+33,317
| New | +$684K |
|
4242
CALL
Vanda Pharmaceuticals
VNDA
$306M
| $780K | ﹤0.01% |
93,300
-4,000
| -4% | -$32.8K |
|
|
4243
PUT
Vanda Pharmaceuticals
VNDA
$306M
| $779K | ﹤0.01% |
93,200
-700
| -0.7% | -$5.75K |
|
|
JNPR
4244
PUT
DELISTED
Juniper Networks
JNPR
| $778K | ﹤0.01% |
30,500
-222,500
| -88% | -$5.56M |
|
4245
PUT
Parker-Hannifin
PH
$126B
| $778K | ﹤0.01% |
7,000
-63,400
| -90% | -$6.37M |
|
4246
PUT
Polaris
PII
$4.16B
| $778K | ﹤0.01% |
7,900
-42,100
| -84% | -$3.65M |
|
4247
Baytex Energy
BTE
$2.9B
| $776K | ﹤0.01% |
195,486
-83,767
| -30% | -$219K |
|
4248
PUT
Novartis
NVS
$294B
| $775K | ﹤0.01% |
11,941
-200,211
| -94% | -$13.6M |
|
4249
CALL
Royal Bank of Canada
RY
$294B
| $771K | ﹤0.01% |
13,400
-9,000
| -40% | -$466K |
|
4250
8x8 Inc
EGHT
$328M
| $768K | ﹤0.01% |
76,316
+44,331
| +139% | +$486K |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.